Try a new search

Format these results:

Searched for:

person:nixonr01 or ginsbs01 or levye01 or mathep01 or ohnom01 or raom01 or scharh01 or yangd02 or yuana01

Total Results:

1148


The neuronal endosomal-lysosomal system in Alzheimer's disease

Nixon RA; Mathews PM; Cataldo AM
Robust activation of the neuronal lysosomal system and cellular pathways converging on the lysosome, such as the endocytic and autophagic pathways, are prominent neuropathological features of Alzheimer's disease. Disturbances of the neuronal endocytic pathway, which are one of the earliest known intracellular changes occurring in Alzheimer's disease and Down syndrome, provide insight into how beta-amyloidogenesis might be promoted in sporadic Alzheimer's disease, the most prevalent and least well understood form of the disease. Primary lysosomal system dysfunction in inherited disorders is commonly associated with prominent neurological phenotypes and neurodegeneration. New studies now directly implicate lysosomal cathepsins as proteases capable of initiating, as well as executing, cell death programs. These and other studies support the view that the progressive alterations of lysosomal system function in Alzheimer's disease have broad relevance to the neurodegenerative processes occurring during the disease
PMID: 12214078
ISSN: 1387-2877
CID: 32538

Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients

Levy E; Sastre M; Kumar A; Gallo G; Piccardo P; Ghetti B; Tagliavini F
Immunohistochemical analysis of brains of patients with Alzheimer disease (AD) revealed that the cysteine proteinase inhibitor cystatin C colocalizes with amyloid beta-protein (Abeta) in parenchymal and vascular amyloid deposits. No evidence of cerebral hemorrhage was observed in any of the brains studied. Immunoelectron microscopy demonstrated dual staining of amyloid fibrils with anti-Abeta and anti-cystatin C antibodies. Cystatin C immunoreactivity was also observed in amyloid deposits in the brain of transgenic mice overexpressing human beta amyloid precursor protein. Massive deposition of the variant cystatin C in the cerebral vessels of patients with the Icelandic form of hereditary cerebral hemorrhage with amyloidosis is thought to be responsible for the pathological processes leading to stroke. Anti-cystatin C antibodies strongly labeled pyramidal neurons within cortical layers most prone to amyloid deposition in the brains of AD patients. Immunohistochemistry with antibodies against the carboxyl-terminus of Abeta(x-42) showed intracellular immunoreactivity in the same neuronal subpopulation. It remains to be established whether the association of cystatin C to Abeta plays a primary role in amyloidogenesis of AD or is a late event in which the protein is bound to the previously formed Abeta amyloid fibrils
PMID: 11202179
ISSN: 0022-3069
CID: 26817

BDNF and epilepsy: too much of a good thing?

Binder, D K; Croll, S D; Gall, C M; Scharfman, H E
Various studies have shown that brain-derived neurotrophic factor (BDNF) increases neuronal excitability and is localized and upregulated in areas implicated in epileptogenesis. Seizure activity increases the expression of BDNF mRNA and protein, and recent studies have shown that interfering with BDNF signal transduction inhibits the development of the epileptic state in vivo. These results suggest that BDNF contributes to epileptogenesis. Further analysis of the cellular and molecular mechanisms by which BDNF influences excitability and connectivity in adult brain could provide novel concepts and targets for anticonvulsant or anti-epileptogenic therapy
PMID: 11163887
ISSN: 0166-2236
CID: 73428

Examining the molecular structure of Alzheimer's amyloid-beta protein

Serpell LC; McLaurin J; Yang DS; Sunde M; Yip CM; Fraser PE
ORIGINAL:0004294
ISSN: 1350-6129
CID: 27552

Neurofilaments

Chapter by: Nixon RA; Rao MV
in: Encyclopedia of molecular medicine by Creighton TE [Eds]
Chichester : Wiley, 2001
pp. 1589-1595
ISBN: 0471374946
CID: 2724

Survival of dentate hilar mossy cells after pilocarpine-induced seizures and their synchronized burst discharges with area CA3 pyramidal cells

Scharfman, H E; Smith, K L; Goodman, J H; Sollas, A L
The clinical and basic literature suggest that hilar cells of the dentate gyrus are damaged after seizures, particularly prolonged and repetitive seizures. Of the cell types within the hilus, it appears that the mossy cell is one of the most vulnerable. Nevertheless, hilar neurons which resemble mossy cells appear in some published reports of animal models of epilepsy, and in some cases of human temporal lobe epilepsy. Therefore, mossy cells may not always be killed after severe, repeated seizures. However, mossy cell survival in these studies was not completely clear because the methods did allow discrimination between mossy cells and other hilar cell types. Furthermore, whether surviving mossy cells might have altered physiology after seizures was not examined. Therefore, intracellular recording and intracellular dye injection were used to characterize hilar cells in hippocampal slices from pilocarpine-treated rats that had status epilepticus and recurrent seizures ('epileptic' rats). For comparison, mossy cells were also recorded from age-matched, saline-injected controls, and pilocarpine-treated rats that failed to develop status epilepticus.Numerous hilar cells with the morphology, axon projection, and membrane properties of mossy cells were recorded in all three experimental groups. Thus, mossy cells can survive severe seizures, and those that survive retain many of their normal characteristics. However, mossy cells from epileptic tissue were distinct from mossy cells of control rats in that they generated spontaneous and evoked epileptiform burst discharges. Area CA3 pyramidal cells also exhibited spontaneous and evoked bursts. Simultaneous intracellular recordings from mossy cells and pyramidal cells demonstrated that their burst discharges were synchronized, with pyramidal cell discharges typically beginning first.From these data we suggest that hilar mossy cells can survive status epilepticus and chronic seizures. The fact that mossy cells have epileptiform bursts, and that they are synchronized with area CA3, suggest a previously unappreciated substrate for hyperexcitability in this animal model
PMCID:2518406
PMID: 11440806
ISSN: 0306-4522
CID: 73429

Experimental aging of the lysosomal system promotes neurodegeneration in the PS/APP mouse model of Alzheimer's disease pathology [Meeting Abstract]

Nixon, R. A.; Mathews, P. M.; Cataldo, A. M.; Mohan, P. S.; Marks, N.; Duff, K.; Berg, M.; Schmidt, S. D.; Jacobsen, S. P.; Jiang, Y.; Sershen, H.
The lysosomal system (LS) is markedly activated in vulnerable neuronal populations early in Alzheimer's disease, although lysosomes become less efficient degradative compartments as neurons become more compromised. LS dysfunction, especially altered activity of the lysosomal protease cathepsin D, has been implicated in cell death initiation under various apoptotic conditions in vivo and in vitro. In this study, we observed that cathepsin D content increases nearly 3-fold in the human neocortex during normal aging while lysosomal cysteine protease activities decrease. By contrast, during aging in the mouse, this protease imbalance and other aging-related changes of the LS, such as lipofuscin accumulation, are minimal in these cortical areas. However, when leupeptin (a cysteine protease inhibitor) was infused intraventricularly, an imbalance of cathepsins similar to that in the aging human brain was induced. This was accompanied by changes associated with cell senescence, including ceroid-lipofuscin accumulation and alterations of tau proteolysis. In PSM146L/APPSWE transgenic mice, super-imposition of this aging-related cathepsin imbalance accentuated preexisting LS abnormalities to the level seen in AD brain and also induced neuronal atrophy and neurodegeneration. The minimal degree of 'lysosomal aging' seen in old mice, compared to that in humans, may partly explain the mild neurodegenerative phenotypes in transgenic models of AD pathology. In addition, these studies provide in vivo evidence relating altered lysosomal function to neurodegeneration
BIOSIS:PREV200100498233
ISSN: 0190-5295
CID: 115690

Localization and induction of expression of the Steriodogenic Acute Regulatory (StAR) protein in rodent brain [Meeting Abstract]

King, S. R.; Manna, P. R.; Ishii, T.; Ginsberg, S. D.; Stocco, D. M.; Walsh, L. P.; Parker, K. L.; Smith, R. G.; Syapin, P. J.; Lamb, D. J.
BIOSIS:PREV200100509382
ISSN: 0190-5295
CID: 449722

Gene expression profiling using single cell microdissection combined with cDNA microarrays

Chapter by: Ginsberg, Stephen D
in: DNA microarrays : the new frontier in gene discovery and gene expression analysis by
[S.l. : Society for Neuroscience], 2001
pp. 61-70
ISBN: n/a
CID: 453202

On the mechanisms underlying compensatory changes in hippocampal excitatory synaptic transmission following chronic activity blockade [Meeting Abstract]

Galvan, C. D.; Dineley, K. T.; Le, J. T.; Sweatt, J. D.; Ginsberg, S. D.; Swann, J. W.
BIOSIS:PREV200200004006
ISSN: 0190-5295
CID: 460962